texte alternatif                                    

    List of publications of Eric Trepo


      Contributions to collective works (1)
  1. 1. Moreno, C., & Trepo, E. (2013). Vitamin D deficiency and liver disease. In V. Arroyo & J. Rodés (Eds.), Advances in therapy of liver diseases. Spain: Ars Medica.
    2.   Peer-reviewed journal articles (88)
  2. 1. Trepo, E., Zucman-Rossi, J., & Nault, J. C. (2026). Germline mutations and somatic mosaicism in steatotic liver diseases and related liver carcinogenesis. Nature Reviews Gastroenterology and Hepatology.
  3. 2. Clusmann, J., Balaguer-Montero, M., Bassegoda, O., Schneider, C. V., Seraphin, T., Paintsil, E., Luedde, T., Lopez, R. P., Calderaro, J., Gilbert, S., Marjot, T., Spann, A., Shawcross, D. L., Lens, S., Trepo, E., & Kather, J. N. (2025). The barriers to uptake of artificial intelligence in hepatology and how to overcome them. Journal of hepatology, 83(6), 1410-1426. doi:10.1016/j.jhep.2025.07.003
  4. 3. Campani, C., Galvanin, C., Shim, J. H., Bouattour, M., Touchefeu, Y., Delhoume, V., Rosmorduc, O., Pascale, A., An, J., Lee, H. C., Regnault, H., Thabut, D., Paradis, V., Calderaro, J., Ziol, M., Beaufrère, A., Sayadi, A., Amaddeo, G., Allaire, M., Olivier-Hourmand, I., Metivier, C., Rondini, E., Ronot, M., Ntandja-Wandji, L., Ozenne, V., Sidali, S., Marra, F., Hollande, C., Ganne-Carrié, N., Nahon, P., Lequoy, M., Sharma, R., Paris Liver Cancer Group,, Ningarahi, M., Trepo, E., & Nault, J. C. (2025). The "A-B-C" Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/Bevacizumab. Clinical gastroenterology and hepatology. doi:10.1016/j.cgh.2025.11.018
  5. 4. Arab, J. P., Díaz, L. A., Rehm, J., Im, G. Y., Arrese, M., Kamath, P. S., Lucey, M. R., Mellinger, J., Thiele, M., Thursz, M. M., Bataller, R., Burton, R., Chokshi, S., Francque, S., Krag, A., Lackner, C., Lee, B. B., Liangpunsakul, S., MacClain, C., Mandrekar, P., Mitchell, M. M., Morgan, M. Y., Morgan, T. R., Pose, E., Shah, V. H., Shawcross, D., Sheron, N., Singal, A. K., Stefanescu, H., Terrault, N., Trepo, E., Moreno, C., Louvet, A., & Mathurin, P. (2025). Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease. Journal of hepatology. doi:10.1016/j.jhep.2024.11.028
  6. 5. Ningarhari, M., Lassailly, G., Dharancy, S., Moreno, C., & Trepo, E. (2025). Recurrence of Hepatocellular Carcinoma After Liver Transplantation: The Blind Spot of HCC Management. United European gastroenterology journal. doi:10.1002/ueg2.70078
  7. 6. Shen, T.-K., Vignane, T., Gilglioni, E. H., Traini, L., Kalaitsidou, E., Conan, P. L., Li, A., St-Pierre-Wijckmans, W., Herranz, J. M., Elvira Jimenez, B., Otero Sanchez, L., Trepo, E., Deelman, L., Wu, W., Filipovic, M. R., Messens, J., Ezeriņa, D., & Gurzov, E. N. (2025). Metabolic dysfunction-associated steatohepatitis reduces hepatic H2S-producing enzymes altering persulfidome composition. Redox Biology, 86, 103809. doi:10.1016/j.redox.2025.103809
  8. 7. Kubina, M., Prasitsumrit, V., Tan, J., Quek, J. W. E., Peddu, D., Mishra, A., Danpanichkul, P., Mann, J. P., Trepo, E., Buch, S., Huang, D. Q., Ng, C. H., Muthiah, M. M., Wong, Y. J., Wijarnpreecha, K., & Chen, V. V. (2025). Meta-Analysis: Effects of Steatotic Liver Disease-Associated Genetic Risk Alleles on Longitudinal Outcomes. Alimentary pharmacology & therapeutics, 62(3), 244-276. doi:10.1111/apt.70256
  9. 8. Cremer, A., Rosewick, N., Kelsey, M., Trepo, E., Libert, F., De Vos, M., Baert, F., Moreels, T., Louis, E., Rahier, J. F., Demetter, P., Sedivy, J. J., Vermeire, S., & Franchimont, D. (2025). A transcriptomic score to classify the inflammation-dysplasia-cancer sequence lesions in inflammatory bowel disease. Journal of Crohn's and Colitis, 19(3), jjaf026. doi:10.1093/ecco-jcc/jjaf026
  10. 9. Galvanin, C., Buch, S., Nahon, P., & Trepo, E. (2025). PNPLA3 in Alcohol-Related Liver Disease. Liver international, 45(1), e16211. doi:10.1111/liv.16211
  11. 10. Chang, C. W., Chen, Y. S., Huang, C. H., Lin, C. H., Ng, W. V., Chu, L. J., Trepo, E., Zucman-Rossi, J., Siao, K., Maher, J. J., Chiew, M. Y., Chou, C. H., Huang, H. D., Teo, W. H., Lee, S. I., Lo, J. F., & Wang, X. W. (2025). A genetic basis of mitochondrial DNAJA3 in nonalcoholic steatohepatitis-related hepatocellular carcinoma. Hepatology (Baltimore, Md.), 81(1), 60-76. doi:10.1097/HEP.0000000000000637
  12. 11. Hadefi, A., Leprovost, M., Dinsart, G., Marefati, M., Vermeersch, M., Monteyne, D., Perez-Morga, D., Lefort, A., Libert, F., Verset, L., Liefferinckx, C., Moreno, C., Devière, J., Trepo, E., & Garcia, M.-I. (2025). Duodenal Organoids From Metabolic Dysfunction-Associated Steatohepatitis Patients Exhibit Absorptive and Barrier Alterations. Gastro Hep Advances, 4(4), 100599. doi:10.1016/j.gastha.2024.100599
    13. << Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next >>